Avicanna Inc (TSX:AVCN, OTCQX:AVCNF) announced that it has completed, through its majority-owned Santa Marta Golden Hemp subsidiary, the commercial export of aureus branded products into Paraguay.
The biopharmaceutical firm said the transaction also marks the 17th international market for Aureus branded products and the 20th market for all Avicanna products, which further demonstrates the company’s capabilities in navigating complex regulatory processes for its commercialization efforts internationally.
Avicanna noted the commercial export included Aureus branded purified cannabidiol (CBD) and cannabigerol (CBG), which is a part of the company’s portfolio of cannabinoid-active pharmaceutical ingredients.
Aureus-branded products are cultivated, extracted, and manufactured by Avicanna’s subsidiaries in Colombia, where they leverage optimal environmental conditions to produce cannabinoid-active pharmaceutical ingredients economically and sustainably and include a range of extracts of CBD, THC and rare cannabinoids such as CBG, according to the company.
Avicanna is a commercial-stage international biopharmaceutical company focused on the advancement and commercialization of evidence-based cannabinoid-based products for the global medical and pharmaceutical market segments.
The company has an established scientific platform including R&D and clinical development that has led to the commercialization of more than 30 products across various market segments.
Contact Sean at sean@proactiveinvestors.com